Author

Hanyujie Kang

Capital Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:clustering· 1 Approach:experimental assay· 1

Frequent Co-Authors

Nan SongiD· 2 shared Siyu CaoiD· 2 shared Xueqing Gu· 2 shared Zhaohui TongiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Nan SongORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologyTranslational researchPeer-reviewedOct 28, 2024

Blockade of TREM2 ameliorates pulmonary inflammation and fibrosis by modulating sphingolipid metabolism

Xueqing Gu, Hanyujie Kang, Siyu Cao…·Nan Song

This study shows that blocking TREM2 reduces pulmonary inflammation and fibrosis by altering sphingolipid metabolism and chemokine expression in macrophages.

31 citationstop 2%

mousescRNA-seq

𝕏 PostBluesky

BioinformaticsEcotoxicology and Environmental SafetyPeer-reviewedAug 23, 2024

Integrated multi-omics analyses reveal the pro-inflammatory and pro-fibrotic pulmonary macrophage subcluster in silicosis

Hanyujie Kang, Xueqing Gu, Siyu Cao…·Nan Song

This study identifies a pro-inflammatory and pro-fibrotic macrophage subcluster in silicosis using multi-omics approaches and shows its potential as a therapeutic target.

17 citationstop 4%

mousescRNA-seq

𝕏 PostBluesky